Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04181099
Other study ID # 2019-01918
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date August 1, 2020

Study information

Verified date April 2021
Source University of Basel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to test the influence of surface finish on biofilm formation on the transmucosal part of zirconia implants in an in vivo study. Sixteen test person will therefore receive an orthodontic apparatus containing the specimens with the respective surfaces and carry them for 2x 24h. The primary outcome is the spectormetrical quantification (OD value) of biofilm on the specimens that have been carried by the test person over 24h. Biofilm will be analysed using scanning electron microscopy.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date August 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - No systematic antibiotic therapy during the last 3 months - Good oral health and compliance (PI and BI <20%) - No sign of parodontal disease or other inflammatory changes in the mouth - Non-smoker Exclusion Criteria: - Disease that requires antibiotic therapy - Pressure marks due to the orthodontic apparatus that can not be eliminated - Other unexpected complications that could be related to the orthodontic apparatus

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Implant neck surface
The biofilm formation is tested on discs manufactured of zirconia with different surfaces in vivo using orthodontic devices that the participants carry over 24h

Locations

Country Name City State
Switzerland University Center for Dental Medicine Basel Basel Basel-Stadt

Sponsors (1)

Lead Sponsor Collaborator
University of Basel

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safranin Staining The biofilm on the discs is quantified using safranin staining and evaluated with the measurement of optical density using a photospectrometer 3 months
Secondary SEM The morphology of the biofilm is analyzed using scanning electron microscopy 3 months